A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...
Examining the impact of geographic distance and social vulnerability on interstitial lung disease care and outcomes is essential, as access barriers disproportionately affect h ...
Early diagnosis and treatment in IPF and PPF are vital, as fibrosis is irreversible and current therapies only slow progression. Current IPF treatments, pirfenidone and nintedanib, have significant ...
Their study has discovered that subtle changes in lung scarring over just one year, as measured by quantitative computed tomography imaging, are strongly linked to future lung-function decline and ...
By Ernie Mundell HealthDay ReporterMONDAY, Nov. 24, 2025 (HealthDay News) — Under current screening guidelines, almost ...
In a study of nearly 1,000 consecutive patients treated for lung cancer at Northwestern Medicine, researchers discovered only ...
A new study shows that the U.S. Preventive Services Task Force screening criteria for lung cancer exclude at-risk patients.
With diseases growing more dangerous over time, AI is poised to change the game in modern medicine’s favor. Read more about ...
In a new study of nearly 1,000 consecutive patients treated for lung cancer at Northwestern Medicine, researchers discovered ...
At 50 years old, my health began to deteriorate in ways no one could explain. For nearly two decades, I searched for answers. It wasn’t until I was 69 that I finally learned the truth: I have cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback